Advertisement
Advertisement

BMY

BMY logo

Bristol-Myers Squibb Co.

54.00
USD
Sponsored
-1.28
-2.32%
Jun 18, 16:00 UTC -4
Closed
exchange

Pre-Market

53.99

-0.01
-0.01%

BMY Earnings Reports

Positive Surprise Ratio

BMY beat 36 of 41 last estimates.

88%

Next Report

Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$11.81B
/
$1.61
Implied change from Q1 26 (Revenue/ EPS)
+2.77%
/
+1.90%
Implied change from Q2 25 (Revenue/ EPS)
-3.76%
/
+10.27%

Bristol-Myers Squibb Co. earnings per share and revenue

On Apr 30, 2026, BMY reported earnings of 1.58 USD per share (EPS) for Q1 26, beating the estimate of 1.43 USD, resulting in a 10.40% surprise. Revenue reached 11.49 billion, compared to an expected 11.02 billion, with a 4.27% difference. The market reacted with a +5.21% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of 1.61 USD, with revenue projected to reach 11.81 billion USD, implying an increase of 1.90% EPS, and increase of 2.77% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Bristol-Myers Squibb Co. reported EPS of $1.58, beating estimates by 10.4%, and revenue of $11.49B, 4.27% above expectations.
The stock price moved up 5.21%, changed from $57.59 before the earnings release to $60.59 the day after.
The next earning report is scheduled for Jul 30, 2026.
Based on 10 analysts, Bristol-Myers Squibb Co. is expected to report EPS of $1.61 and revenue of $11.81B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement